Covenant Health Earns APEx Accreditation for Radiation Oncology Services

May 21, 2024 Meredith Cunningham

We are proud to announce Covenant Health has successfully attained accreditation from the American Society for Radiation Oncology (ASTRO) APEx - Accreditation Program for Excellence®. APEx provides external validation that a radiation oncology facility is delivering high-quality patient care.

The team of doctors, nurses, and technicians at Joe Arrington Cancer Research & Treatment Center earned this designation after undergoing a rigorous multi-step process during which a radiation oncology practice is evaluated using consensus-based standards. The practice must demonstrate its safety and quality processes and show that it adheres to patient-centered care by promoting effective communication, coordinated treatments and strong patient engagement.

"Our radiation oncology team was invested in evaluating our processes to meet ASTRO's high standards for safety and quality,” said Dr. Gabriel Axelrud, Medical Director. “Achieving APEx accreditation shows our community that we are dedicated to delivering consistently safe patient-centered cancer care."

APEx, the fastest-growing radiation oncology practice accreditation program in the United States, is the only radiation oncology accreditation program that includes a self-assessment, which allows practices to internally assess compliance with quality improvement standards. The practice then proceeds to a facility review by an external surveyor team that includes a radiation oncologist and a medical physicist. The program reflects the recommendations endorsed in the ASTRO publication Safety is No Accident: A Framework for Quality Radiation Oncology and Care. To date, more than 300 U.S. facilities have earned APEx accreditation. Learn more about APEx at www.astro.org/APEx.

Previous Article
With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model
With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model

A joint study between Providence, Microsoft and the University of Washington detailing work to create a nov...

Next Article
Cancer studies seek to harness the power of the immune system
Cancer studies seek to harness the power of the immune system

Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcino...